Neuromodulation

MINNEAPOLIS, Minn., July 1, 2026 Saluda Medical has achieved a major regulatory milestone with the U.S. Food and Drug...

ESPOO, Finland, June 30, 2026 Orion Pharma has announced a strategic agreement with Shilpa Biologicals Private Limited, a wholly...

ST. LOUIS, Mo., June 30, 2026 Aurenar has announced that the U.S. Food and Drug Administration (FDA) has granted...

VALENCIA, Calif., June 29, 2026 Bioness Medical, Inc. has announced that the U.S. Food and Drug Administration (FDA) has...

HOUSTON, Texas, June 16, 2026 Nexalin Technology announced that two clinical abstracts evaluating its proprietary Deep Intracranial Frequency Stimulation...

OSLO, Norway, June 16, 2026 SonoClear AS has announced that findings from its pivotal multicenter study evaluating the SonoClear®...

LOS ANGELES, June 16, 2026 Nervonik Inc., a clinical-stage medical device company focused on next-generation neuromodulation technologies, has announced...

NEWPORT BEACH, Calif., June 11, 2026 Wave Neuroscience announced that the U.S. Food and Drug Administration (FDA) has granted...

GALWAY, Ireland, May 20, 2026 Medtronic plc has announced its intent to acquire SPR Therapeutics, Inc. in a deal...

San Mateo, California & Chicago, Illinois, U.S. | April 15, 2026 Cala Health has announced a major regulatory milestone...